Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment

Parts of this work were presented at the Symposium on Advanced Wound Care and Medical Research Forum on Wound Repair, April 18-22, 1998, Miami Beach, Fla.
https://doi.org/10.1053/ic.1998.v26.a93527Get rights and content

Abstract

Background: Antibiotic-resistant bacteria represent an increasing concern in wound infections. Wound colonization with these organisms normally results in aggressive management of the wound complicated by a greatly limited choice of therapeutic antibiotics. Silver and other noble metals are recognized as potential allies in combating these organisms in wounds. Methods: Three types of topical silver applications were tested to determine their bactericidal efficacies against clinical isolates of antibiotic-resistant organisms. The silver-based applications represent 3 methods of applying silver to wounds: as a liquid (silver nitrate), incorporated in a cream (silver sulfadiazine) and as a dressing coating (silver-coated dressings). The reduction in the viable bacterial population recovered from test articles after exposure to silver provided a comparative measure of the bactericidal efficacies of these silver applications. Results: All of the products demonstrated an ability to reduce the number of viable bacteria. However, the methods varied in their efficacy against antibiotic-resistant bacteria, with the silver-coated dressing being the most efficacious and silver nitrate the least efficacious. Conclusions: Silver was demonstrated to be effective at killing the antibiotic-resistant strains tested. The silver-coated dressing was particularly rapid at killing the tested bacteria and was effective against a broader range of bacteria. Silver may be a useful prophylactic or therapeutic agent for the prevention of wound colonization by organisms that impede healing, including antibiotic-resistant bacteria. (AJIC Am J Infect Control 1998;26:572-7)

Section snippets

Bacteria

The bacterial strains were clinical isolates obtained from either Calgary (Alberta, Canada) Laboratory Services or from the University of Toronto Hospital (Toronto, Ontario, Canada). The bacteria are listed in Table 1, with the antibiotics to which they have tested resistant.table

. Antibiotic-resistant clinical isolates, their sites of isolation, and the antibiotics to which they were found to be resistant (as determined by the clinical laboratory in which they were identified)

OrganismIsolation

Bactericidal assay

The bactericidal assay chosen to demonstrate the efficacy of topical silver treatments allowed for accurate determination of the effect of the silver. Rather than describing an inhibitory effect on bacteria, this assay allowed for the determination of the ability of the silver protocols to kill the bacterial inocula. In addition, the method provides the ability to determine the rate of bacterial killing, thereby providing another index of efficacy against the isolates described.

Efficacy against antibiotic-resistant bacteria

The 3 different

DISCUSSION

Bacterial resistance to antibiotics is becoming a major challenge in all parts of the world with the impact on the practice of medicine being seen most acutely. At an increasing frequency, organisms are being isolated that have minimal antibiotic sensitivity or that are sensitive to an increasingly narrow range of antibiotics. Colonization of wounds by antibiotic-resistant organisms provides a significant challenge to the health care community, particularly in patients who may be

References (18)

There are more references available in the full text version of this article.

Cited by (284)

View all citing articles on Scopus

From Westaim Biomedical Corp.

View full text